Delivery Order SPE2DR25D2014-SPE2DR26FA0G7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,066.50 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials. This competitive award, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,239.00 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by July 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The delivery order represents...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,265.22 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials. This firm fixed-price contract, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a non-set-aside competitive award to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $17,704.70 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials. This firm fixed price, non-set-aside contract was awarded on September 25, 2025, with an ultimate completion date of September 26, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,475.68 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials. This firm fixed-price contract, awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a routine pharmaceutical procurement to support federal medical supply needs. The contract is not set-aside and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a...
- The Defense Logistics Agency awarded a delivery order valued at $12,893.58 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 mL vials on May 6, 2025, with completion scheduled for May 7, 2025. This non-set-aside, firm fixed-price contract represents a routine pharmaceutical procurement under AmerisourceBergen's broader federal supply agreement. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $21,873.30 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Injectafer 750 mg/15 ml vials. This firm fixed-price, competitively awarded contract is scheduled for completion by August 11, 2025, with performance based in Conshohocken, Pennsylvania. The award represents a non-set-aside procurement, indicating AmerisourceBergen competed against other vendors to secure this pharmaceutical supply delivery. This delivery order...
- The Defense Logistics Agency awarded a $26,818.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Injectafer 750 mg/15 ml vials. The contract, which is a non-set-aside award, has an ultimate completion date of September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,260.48 to supply Injectafer 750 mg/15 mL vials. The order, issued on December 18, 2025, with completion targeted for December 19, 2025, represents a firm fixed price delivery under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, fulfilled this requirement as part of its federal pharmaceutical supply portfolio serving military and veteran...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,998.79 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 mL vials. The contract was awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, and utilizes firm fixed price terms with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA0G7Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,747.15 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 mL vials. This is a firm fixed-price, competitive delivery order with an ultimate completion date of December 22, 2025, with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical commodities globally to support military healthcare programs, including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies. The company's consistent receipt of competitive delivery orders across multiple therapeutic domains demonstrates its established capability to meet federal pharmaceutical procurement requirements efficiently.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 12/18/25 |